Literature DB >> 26550933

Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014).

James C Lamb1, Paolo Boffetta2, Warren G Foster3, Julie E Goodman4, Karyn L Hentz5, Lorenz R Rhomberg6, Jane Staveley7, Gerard Swaen8, Glen Van Der Kraak9, Amy L Williams10.   

Abstract

Recently Bergman et al. (2015) took issue with our comments (Lamb et al., 2014) on the WHO-UNEP(1) report entitled the "State of the Science of Endocrine Disrupting Chemicals - 2012" (WHO 2013a). We find several key differences between their view and ours regarding the selection of studies and presentation of data related to endocrine disrupting chemicals (EDCs) under the WHO-IPCS(2) definition (2002). In this response we address the factors that we think are most important: 1. the difference between hazard and risk; 2. the different approaches for hazard identification (weight of the evidence [WOE] vs. emphasizing positive findings over null results); and 3. the lack of a justification for conceptual or practical differences between EDCs and other groups of agents.
Copyright © 2015 Elsevier Inc. All rights reserved.

Keywords:  Endocrine disrupting chemicals (EDC); Endocrine mode-of-action; Hazard assessment; Risk characterization; Weight of evidence

Mesh:

Substances:

Year:  2015        PMID: 26550933     DOI: 10.1016/j.yrtph.2015.10.029

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  8 in total

Review 1.  Metabolism disrupting chemicals and metabolic disorders.

Authors:  Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal
Journal:  Reprod Toxicol       Date:  2016-10-17       Impact factor: 3.143

Review 2.  Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals.

Authors:  Anna Beronius; Laura N Vandenberg
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

3.  Novel insights into di‑(2‑ethylhexyl)phthalate activation: Implications for the hypothalamus‑pituitary‑thyroid axis.

Authors:  Haoyu Wu; Wanying Zhang; Yunbo Zhang; Zhen Kang; Xinxiunan Miao; Xiaolin Na
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

Review 4.  Membrane Hormone Receptors and Their Signaling Pathways as Targets for Endocrine Disruptors.

Authors:  Yves Combarnous; Thi Mong Diep Nguyen
Journal:  J Xenobiot       Date:  2022-03-25

Review 5.  Role of Non-Coding RNAs in the Transgenerational Epigenetic Transmission of the Effects of Reprotoxicants.

Authors:  Eduardo Larriba; Jesús del Mazo
Journal:  Int J Mol Sci       Date:  2016-03-25       Impact factor: 5.923

Review 6.  Evidence of the Possible Harm of Endocrine-Disrupting Chemicals in Humans: Ongoing Debates and Key Issues.

Authors:  Duk Hee Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2018-03

Review 7.  Comparative Overview of the Mechanisms of Action of Hormones and Endocrine Disruptor Compounds.

Authors:  Yves Combarnous; Thi Mong Diep Nguyen
Journal:  Toxics       Date:  2019-01-24

Review 8.  Endocrine disrupting chemicals in the pathogenesis of hypospadias; developmental and toxicological perspectives.

Authors:  Deidre M Mattiske; Andrew J Pask
Journal:  Curr Res Toxicol       Date:  2021-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.